Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Phage (PTXX): Antibiotics to fight super-resistant bugs

No earlier versions found for this Subject.

Return to Phage (PTXX): Antibiotics to fight super-resistant bugs

I saw a TV report indicating that this company is working on a safe antibiotic against superbugs. Information was rather sketchy.

Could some one speak to this company"s propsects and /or other cccompanies working on antibiotics for highly resistant, often fatal, strains- usually found in hospitals. I know this sounds dramatic- but it isn"t meant to be.

I am not a shareholder and am not recommending this stock to anyone. Simply seeking more information about their science and of their compatitors'. Thanks in advance.